Infosys Share Price Target 2026: Brokerage firm Nomura has maintained Buy rating on Infosys shares. The brokerage has set a target price of Rs 1,810 on Infosys stock.
The target of Rs 1,810 offers an upside of more than Rs 531 or 40 per cent from Wednesday's close of Rs 1,278.60.
Infosys has just announced the acquisitions of Optimum Healthcare (unlisted) and Stratus (unlisted) with a total investment of USD 560m million.
Nomura said that it as retained Buy rating on Infosys based on 23x 1H FY28F EPS. Infosys shares currently trades at 16.9x FY27F EPS and 15.9x FY28F EPS.
Optimum Healthcare is a healthcare technology consulting provider. Infosys said that the acquisition gives it access to 1,600+ experts with deep healthcare provider domain expertise. The deal will also enhances Infosys' presence in the provider segment, add new clients, expand technology capabilities and create synergies across new buying center.
Optimum Healthcare was founded in 2012, is headquartered in Florida, US.
Optimum reported a revenue of USD 275.9 million in FY25, USD 106.6 million in FY24 and USD 114.3 million in FY23 (FY ending December).
Stratus is an insurance consulting technology company. Its acquisition will gives Infosys access to 450+ experts with deep industry knowledge, consulting excellence, and advanced technology capabilities.
Stratus was founded in 2001, headquartered in New Jersey, US. Stratus operates with delivery teams across the US, Canada, and India.
Stratus reported a revenue of USD 42.8 million in FY25, USD36.2 million in FY24 and USD 35.1 million in FY23 (FY ending December).
Both the acquisitions by Infosys are expected to close by June 2026. The deal is subject to regulatory and statutory approvals.



